Enzyme modulators and treatments

Details for Australian Patent Application No. 2005321946 (hide)

Owner Deciphera Pharmaceuticals, LLC

Inventors Petillo, Peter A.; Flynn, Daniel L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005321946

PCT Pub. Number WO2006/071940

Priority 60/638,986 23.12.04 US; 60/638,987 23.12.04 US; 60/639,087 23.12.04 US; 60/638,968 23.12.04 US

Filing date 23 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 16 August 2012

International Classifications

C07C 275/28 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

A61K 31/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/071940 Priority application(s): WO2006/071940

16 August 2012 Application Accepted

  Published as AU-B-2005321946

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321958-Compositions and methods for improving kidney function

2005321940-Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs